Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRIS (Intelligent Retinal Imaging Systems) is a healthcare technology company focused on ending preventable blindness through early detection of vision-threatening diseases. The company provides an FDA-cleared, cloud-based platform that integrates with fundus cameras to perform teleretinal screenings, primarily for diabetic retinopathy, in primary care settings. By leveraging advanced image enhancement and diagnostic software, IRIS enables healthcare providers to identify pathology early and refer patients to specialists for timely treatment. Their end-to-end solution includes hardware integration, image interpretation by a remote network of ophthalmologists, and seamless electronic health record (EHR) connectivity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on I.R.I.S.